Kezar Life Sciences, Inc.

NASDAQ:KZR

7.09 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 00-5.428700000000000000000000000000
Kosten van de omzet 0.2610.260.280.2780.2490.25913.0010.4580.4310.4170.3870.3780.3730.3720000000000000000
Brutowinst -0.261-0.26-5.7086.722-0.249-0.259-13.001-0.458-0.431-0.417-0.387-0.378-0.373-0.3720000000000000000
Brutowinstmarge 001.0520.9600000000000000000000000000
Onderzoek- en ontwikkelingskosten 16.29817.17222.64223.73820.99918.3184.85913.8611.34610.9449.78110.5279.3419.2868.1178.2597.1487.4577.4317.086.9255.9274.6734.6645.2283.5721.6361.5571.4451.831
Algemene en administratieve kosten 5.6036.5395.768.7895.7856.2065.1755.0674.9774.9344.3223.9723.6683.7622.9513.2922.7053.0212.5662.6012.432.3821.7531.61.7221.5140.7830.6350.4360.426
Verkoop- en marketingkosten -0.261-0.26-0.28000000000000000000000000000
Verkoop-, algemene en administratieve kosten 5.3426.2795.488.7895.7856.2065.1755.0674.9774.9344.3223.9723.6683.7622.9513.2922.7053.0212.5662.6012.432.3821.7531.61.7221.5140.7830.6350.4360.426
Overige kosten 1.48206.187000100000.0010000000000000000000
Bedrijfskosten 21.6423.45128.12232.52726.78424.52420.03418.92716.32315.87814.10314.49913.00913.04811.06811.5519.85310.4789.9979.6819.3558.3096.4266.2646.955.0862.4192.1921.8812.257
Bedrijfsresultaat -21.901-23.711-28.402-25.527-26.784-24.524-20.034-18.927-16.323-15.878-14.103-14.499-13.009-13.048-11.068-11.551-9.853-10.478-9.997-9.681-9.355-8.309-6.426-6.264-6.95-5.086-2.419-2.192-1.881-2.257
Bedrijfsresultaat ratio 005.232-3.64700000000000000000000000000
Totaal overige inkomsten en kosten netto 0.3542.053-3.8582.4242.4762.3251.8531.080.136-0.146-0.1090.0370.0470.0540.1270.2620.3530.4660.4180.5330.6370.6670.6440.6010.1750.1390.1190.1120.0010
Inkomen voor belasting -21.547-21.658-32.26-23.103-24.308-22.199-18.181-17.847-16.187-16.024-14.212-14.462-12.962-12.994-10.941-11.289-9.5-10.012-9.579-9.148-8.718-7.642-5.782-5.663-6.775-4.947-2.3-2.08-1.88-2.257
Inkomen voor belasting ratio 005.943-3.300000000000000000000000000
Belastingkosten 00.217-0.628-0.2782.861-1.955-1.853-1.080.4080.146-0.337-0.10800-0.3680-0.3690-0.34-0.33300-0.2040000000
Nettowinst -21.547-21.658-32.26-23.103-24.308-20.244-16.328-16.767-16.187-16.17-14.212-14.462-12.962-12.994-10.941-11.289-9.5-10.012-9.579-9.148-8.718-7.642-5.782-5.663-6.775-4.947-2.3-2.08-1.88-2.257
Nettowinstmarge 005.943-3.300000000000000000000000000
WPA (Winst Per Aandeel) -0.3-0.3-0.44-0.32-0.34-0.28-0.23-0.23-0.25-0.27-0.25-0.28-0.25-0.25-0.22-0.23-0.22-0.2-0.5-0.48-0.46-0.4-0.3-0.3-3.31-0.28-0.18-0.16-0.14-0.17
Verwaterde WPA -0.3-0.3-0.44-0.32-0.34-0.28-0.23-0.23-0.25-0.27-0.25-0.28-0.25-0.25-0.22-0.23-0.22-0.2-0.5-0.48-0.46-0.4-0.3-0.3-3.31-0.28-0.18-0.16-0.14-0.17
EBITDA -21.64-23.451-28.122-25.527-23.674-21.829-20.034-17.079-15.484-15.353-14.053-14.121-12.636-12.676-11.068-11.106-9.853-10.116-9.997-9.681-9.03-8.006-6.426-6.059-6.756-4.999-2.374-2.149-1.838-2.213
EBITDA ratio 005.181-3.64700000000000000000000000000